What’s new?
Keep an eye on our news feed, where we’ll publish everything that’s happening in the world of Salts Healthcare.
Mayor of West Midlands Opens New Facilities at Salts Healthcare
West Midlands Mayor, Andy Street, officially opened two new research and education facilities here at Salts Healthcare. Over £2M has been invested in the Salts Academy – a new education venue for health care professionals, and the Central Skin Sciences Institute, an independent skin research facility, as Salts continues to grow in its fourth century of operation.
The Salts Academy is a dedicated facility providing high-quality educational courses up to and including masters level for healthcare professionals specialising in stoma care. Founded in 2012 it is the only one of its type in the UK and, due to its continued success, and commitment to offer quality education to nurses that will ultimately improve the lives of patients, Salts has now invested further in creating a new purpose-built space. This space now includes a lecture theatre, library, and clinical skills room for specialist nurses to visit and further their knowledge, skills and understanding of stoma care.
The Salts Academy has partnered with De Montfort University for ten years, and more recently Birmingham City University, providing stoma care education for healthcare professionals and other healthcare workers in the form of workshops, study days and courses leading to qualifications at degree and masters level.
Angie Perrin, Clinical Education Lead at The Salts Academy said, “This new venue means we can expand our educational services for nurses that will, in turn, assist in helping patients. The specialist facilities will create the perfect platform for educators to connect with students and practitioners and provide high quality evidence-based care education.”
The Central Skin Sciences Institute (CSSI) is a new purpose-built facility that will generate scientific data through research and testing to advance knowledge in the area of skin health and skin adhesives.
These new insights and understanding of skin health will have numerous benefits for people living with a stoma, manufacturers, and medical professionals. From improving medical provision to driving innovation in the development of medical adhesives, the knowledge will ultimately help enhance the quality of life for people living with a stoma.
The clinical research studies at the Central Skin Sciences Institute will encompass people living with a stoma, as well as ‘healthy skin’ volunteers. Studies will look into the characteristics of the skin, including the specifics of the skin surrounding stomas.
Mireille Hamson, Clinical Research Manager at the CSSI said, “We believe that the Central Skin Sciences Institute will combine skin health research, with reliable, innovative testing methods and clinical expertise to generate both questions and find answers that can make a real-life difference.”
“Our clinical investigations will generate robust skin health data and knowledge that will support the research and development of new adhesive technology for medical devices and will ultimately change people’s lives.”
Commenting on the dual-launch Andy Street said, “The West Midlands is at the heart of the UK’s life science sector and so I’m delighted to help officially open these two impressive venues. Salts’ continued investment in R&D, training and education is helping the development of the life sciences industry across here in the West Midlands and beyond, and ultimately helping to improve the lives of hundreds of thousands of patients across the globe.”
Following the official opening Robert Salt, Managing Director, said “I am so proud of this initiative, and the wonderful team that have not just delivered but has surpassed what I hoped was possible. The thought, the attention to detail, the care that they have put into creating the venues, I can do no more than thank and applaud."
Peter Salt, Chief Executive, continued by saying, “Both the Salts Academy and Central Skin Sciences Institute are unique and are game-changers for the stoma care industry and, most importantly, will have a huge positive affect on patients not just in the UK, but across the World.”
Watch the video here: